Key result
Ginsenoside Rb2, identified as the active component in YQFM, promoted the proliferation of ECV304 and EPCs cells and increased the area of sub-intestinal vessels in zebrafish at 2.5–/mL.
Why the study?
To establish an online CMC-LC/MS method to screen and verify the active pro-angiogenic components of Yiqi Fumai lyophilization injection.
Ginsenoside Rb2 is identified as the active pro-angiogenic component in YQFM using a novel online CMC-LC/MS screening method.
Answers are grounded in this paper and cite their sources.
May guide targeted YQFM studies in angiogenesis models; leaves open clinical translation pending human data.
Objective In this study, an online CMC–LC/MS method was established in order to screen the active components of Yiqi Fumai lyophilization injection (YQFM) related to angiogenesis. The pro-angiogenic active components of YQFM were screened using this system and were then further verified. Methods The ECV304/CMC model coupled online with an HPLC–MS system was initially developed to screen, analyze, and identify the allergenic components of YQFM. A fraction was retained on the ECV304/CMC column, which was identified as ginsenoside Rb 2 . A cell proliferation assay and zebrafish intestinal microvascular model labeled with green fluorescence were used to detect the proliferation effect of ginsenoside Rb 2 . Results (1) The active component in YQFM, which was retained on the column, was ginsenoside Rb 2 . (2) Within a concentration range of 2.5–20 μg/mL, ginsenoside Rb 2 was shown to promote the proliferation of ECV304 and EPCs cells and increase the area of sub-intestinal vessels in zebrafish. Conclusion Ginsenoside Rb 2 , the active component in YQFM, can promote angiogenesis. The ECV304/CMC-online-HPLC system may serve as an effective screening tool for the vasoactive components from the traditional Chinese medicine injection.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2023) studied Angiogenesis. Ginsenoside Rb2 (active component of YQFM) was evaluated on Proliferation of ECV304 and EPCs cells and area of sub-intestinal vessels in zebrafish. Ginsenoside Rb2, identified as the active component in YQFM, promoted the proliferation of ECV304 and EPCs cells and increased the area of sub-intestinal vessels in zebrafish at 2.5–/mL.
Synapse has enriched 10 related papers. Consider them for comparative context: